GlaxoSmithKline/Bayer Vardenafil Copromotion May Include Quid Pro Quo

Bayer may get rights to a GlaxoSmithKline product through a potential quid pro quo arrangement in the companies' copromotion agreement for Bayer's erectile dysfunction product vardenafil

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet